Privigen 10% vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFBW9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,955
Award facts
- Contract value 100% obligated
- $35,955.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,955.00 to DMS Pharmaceutical Group Inc. for Privigen 10% Vial 200ml on January 15, 2026, with an ultimate completion date of February 6, 2026. This firm fixed-price delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the open market. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected to supply this intravenous immunoglobulin (IVIG) product to support federal pharmaceutical supply needs.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support military healthcare facilities worldwide. As a single-award prime vendor contractor under this program, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and capability to fulfill diverse pharmaceutical requirements across multiple therapeutic categories for Department of Defense operations.
Quick answers
Who was awarded contract SPE2DR26FFBW9?
SPE2DR26FFBW9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FFBW9 worth?
The government has obligated $35,955 on SPE2DR26FFBW9.
Is contract SPE2DR26FFBW9 an order under another contract?
Yes. SPE2DR26FFBW9 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBW9 competed?
The extent of competition for SPE2DR26FFBW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award